SPRUCE BIOSCIENCES, INC. - 10-Q Filing

Spruce Biosciences reports Q3 financial results including details on Avenue loan agreements, warrant liabilities, and private placement activity.

SEC EDGAR ·

Tickers: $SPRB

Read the full article at SEC EDGAR

More Regulatory news